Moderna stock surged to a five-year high Friday on the back of its Street-walloping vaccine sales and guidance hike for the year.
Yahoo
Skip to navigation
Skip to main content
Skip to right column
Moderna Hits Five-Year High On Sales Beat; But The Real Story Is Still Its Cancer Vaccine ·
Investor's Business Daily
